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Abstract
Background: Digestive damage due to Chagas disease (CD) occurs in 15–20% of patients diagnosed as a result of peristaltic
dysfunction in some endemic areas. The symptoms of chronic digestive CD are non-specific, and there are numerous
confounders. Diagnosis of CD may easily be missed if symptoms are not evaluated by a well trained physician. Regular tests,
as barium contrast examinations, probably lack the necessary sensitivity to detect early digestive damage.
Methods: 71 individuals with T. cruzi infection (G1) and 18 without (G2) coming from Latin American countries were
analyzed. They were asked for clinical and epidemiological data, changes in dietary habits, and history targeting digestive
and cardiac CD symptoms. Serological tests for T. cruzi, barium swallow, barium enema, an urea breath test, and esophageal
manometry were requested for all patients.
Principal findings: G1 and G2 patients did not show differences in lifestyle and past history. Fifteen (21.1%) of G1 had
digestive involvement. Following Rezende criteria, esophagopathy was observed in 8 patients in G1 (11.3%) and in none of
those in G2. Manometry disorders were recorded in 34 G1 patients and in six in G2. Isolated hypotensive lower esophageal
sphincter (LES) was found in sixteen G1 patients (23.9%) and four G2 patients (28.8%). Achalasia was observed in two G1
patients. Among G1 patients, ineffective esophageal motility was seen in six (five with symptoms), diffuse esophageal
spasm in two (one with dysphagia and regurgitation), and nutcracker esophagus in three (all with symptoms). There were
six patients with hypertonic upper esophageal sphincter (UES) among G1. Following Ximenes criteria, megacolon was found
in ten G1 patients (13.9%), and in none of the G2 patients.
Conclusions: The prevalence of digestive chronic CD in our series was 21.1%. Dysphagia is a non-pathognomonic symptom
of CD, but a good marker of early esophageal involvement. Manometry could be a useful diagnostic test in selected cases,
mainly in patients with T. cruzi infection and dysphagia in whose situation barium swallow does not evidence alterations.
Constipation is a common but non-specific symptom that can be easily managed. Testing for CD is mandatory in a patient
from Latin America with constipation or dysphagia, and if diagnosis is confirmed, megacolon and esophageal involvement
should be investigated.
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Introduction
Due to migratory flows, chronic Trypanosoma cruzi infection, or
chronic Chagas disease (CD), has become relatively common in
traditionally non-endemic countries [1]. This symptomatic form of
CD, which affects approximately 40% of patients, is characterized
by cardiac and digestive complications that can progress if the
disease is not diagnosed and managed early [2,3]. Approximately
15–20% of patients with chronic CD develop digestive alterations
in some endemic areas [3], and although mortality is low, patient
quality of life can be severely impaired. Digestive damage due to
chronic T. cruzi infection occurs as a result of peristaltic
dysfunction, and the final stage, megaviscera, is a consequence
of neuronal destruction of the enteric nervous system [4,5,6]. The
damage is variable in terms of progression and extent of
involvement of the digestive tract.
The presence of cardiac, digestive, or mixed (cardiac and
digestive) involvement has been related to the geographical
distribution of T. cruzi serotypes [7–10]. Cardiac involvement in
chronic stages of CD has been widely described [2,11], but
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digestive involvement remains poorly characterized in many areas.
Digestive megaviscera seems to be more common in central Brazil,
less frequent in Bolivia, and practically non-existent in countries
north of the Amazon basin, Central America, and Mexico [6–8].
Megacolon is usually the final manifestation, since onset of
symptoms is slower than in the case of esophageal involvement
[12]. In non-endemic areas, the prevalence of digestive manifes-
tations in CD varies according to immigration patterns.
Even if in recent studies [13] dysphagia appeared as a specific
and constant symptom in patients with megaesophagus, in general
the symptoms of chronic digestive CD are non-specific, and there
are numerous confounders, including other common infections
[14,15], megacolon at high altitude, and gastrointestinal problems
related to the long-term consumption of coca leaves [16–18] or to
migration-related changes in diet [19,20] and stress. A diagnosis of
CD may easily be missed if symptoms are not evaluated by a
physician who knew of the epidemiology and the symptoms of the
disease.
Barium contrast examinations are used to diagnose digestive
involvement in CD [21,22]. and it is possible to establish a
classification in four groups based on the severity of the damage
following Rezende criteria [22].The value of other diagnostic tools
in the detection of early esophageal and colonic involvement in
CD patients is unknown.
The objectives of our study were to determine the prevalence of
digestive damage in patients with CD at an international health
center in a non-endemic area and to study the utility of esophageal
manometry in the early diagnosis of esophageal disease.
Materials and Methods
Ethics Statement
Written informed consent was obtained from participants before
being recruited. Approval for the protocols and for the informed
consent was obtained from the Hospital Clı́nic of Barcelona Ethics
Review Committee.
Design and Setting
This was a prospective study of 89 individuals: 71 with T. cruzi
infection (Group 1, G1) and 18 without infection but with T. cruzi-
like digestive symptoms (Group 2, G2). All the patients were from
Latin American countries where CD is endemic and were seen at
the Center for International Health at a university hospital in
Barcelona, Spain.
Participants and Procedures
Eighty-nine individuals from T. cruzi-endemic areas who were
over 18 years old and living in Barcelona were invited to
participate in the study. After signing the informed consent form,
they were asked for clinical and epidemiological data, including
age, sex, toxic habits, past medical history, geographical origin,
residence in rural environments and mud houses, previous contact
with the T. cruzi vector, and history of blood donation or
transfusion. Changes in dietary habits and weight since arrival in
Spain were also recorded. A detailed history targeting digestive
and cardiac symptoms of CD was also obtained in each case.
Regarding constipation evaluation, Rome III criteria were taken
in account [23].
Serological tests for T. cruzi and HIV infection and routine
blood and biochemical tests (including renal and liver function)
were performed in all cases.
Barium swallow, barium enema, a urea breath test, and
esophageal manometry were requested for all patients. T. cruzi–
infected patients were also studied using a protocol that included a
12-lead electrocardiogram, chest X-ray, and echocardiogram.
Other tests were performed depending on individuals’ symptoms.
Following international recommendations [24], specific treat-
ment with benznidazole (5 mg/kg/d for 60 days) was offered to all
patients with T. cruzi infection.
Diagnosis of T. cruzi Infection
For the laboratory diagnosis of T. cruzi infection, three serum
ELISA tests were performed: a commercial ELISA kit with
recombinant antigens (BioELISA Chagas, Biokit S.A., Lliçà
d’Amunt, Barcelona, Spain), an in-house ELISA kit (whole T.
cruzi epimastigote antigen) [25], and a conventional ELISA kit
(Orthoclinical Diagnostics, Johnson & Johnson Company). Par-
ticipants were considered to be infected if the results from at least
two of the tests were positive [26].
Radiological Studies
The barium swallow was performed following the Rezende
technique [27]. In brief, 200 mL of barium contrast was
administered to the patient in an erect position and right anterior
oblique projections were taken. The contrast was administered
until a column of sufficient height was obtained to ensure passage
to the stomach, allowing visualization of the shape, diameter, wall
contours, and kinetic activity of the esophagus. X-rays were taken
at the time of administration and after 60 seconds.
Barium enema was performed without prior preparation
following the Ximenes technique [28]. Briefly, plain abdominal
X-rays were obtained and the patient was administered 300 mL of
barium contrast diluted in 1200 mL of water to form 1500 mL of
suspension, and asked to remain in the right lateral position for
5 minutes. Three radiological projections (dorsal decubitus,
ventral decubitus, and lateral) were obtained after contrast
administration. Based on the Ximenes criteria, megacolon is
diagnosed when the diameter is .6.5 cm in the descending colon,
.8 cm in the ascending colon, and .12 cm in the cecum.
Urea Breath Test
For the urea breath test, which detects Helicobacter pylori
infection, the patients were administered a capsule containing urea
labeled with 13-C, which was then measured in exhaled CO2
samples. The principle of the test is based on hydrolysis of the non-
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radioactive isotope 13-C to CO2 by the H. pylori enzyme urease.
The CO2 is then transported by the blood to the lungs, where it is
exhaled.
Esophageal Manometry
Esophageal manometry, also known as an esophageal motility
study, was performed in both groups as previously described
[29,30]. Esophageal body motility and lower esophageal sphincter
(LES) pressures were measured using a four-lumen radially
oriented polyvinyl tube with orifices spaced at 5-cm intervals
(98–3113; Mui Scientific Mississauga, Ontario, Canada). Each
lumen was perfused with distilled water (0.5 mL/min) using a low
compliance hydraulic system (Bios Biotechnology & Software,
Barcelona, Spain). Pressures were recorded by means of a pressure
transducer (9022K0122; CODAN pvb Medical GmbH, Lensahn,
Germany) connected via amplifiers to a chart recorder (Polygraf
ID, Medtronic Functional Diagnostics, Skovlunde, Denmark) and
analyzed by the Polygram 98 V 2.20 esophageal application
(Medtronic Functional Diagnostics). Swallowing was monitored by
a sensor wrapped around the patient’s neck.
Overnight fasting was required in all cases, and the patients
were placed in the supine position following insertion of the
manometric tube through the nasal passage. Resting LES pressure
was measured with the station pull-through technique, using
intragastric pressure as the zero reference. The pull-through was
performed three times. LES relaxation was assessed after a
minimum of five swallows of 5-ml water and esophageal body
peristalsis was assessed after a minimum of ten 5-ml swallows at
least 30 seconds apart. We also measured upper esophageal
sphincter location and resting pressure and assessed pharyngo-
esophageal coordination after a minimum of five 5-ml swallows.
Statistical Analysis
Quantitative variables were presented as medians and inter-
quartile range (IQR). Qualitative variables were reported using
absolute frequencies and percentages The analyses were per-
formed using Stata 13 (Stata Corporation, College Station, TX).
Results
We analyzed 71 individuals with T. cruzi infection (G1) and 18
without (G2). The mean age of the patients was 34 (12) years and
there were 75 women (84%) (59 in G1 and 16 in G2). The patients
were mainly from Bolivia (n = 83, 93%). In G1, 69 patients had at
least one digestive symptom and in G2, all the patients were
symptomatic. The baseline characteristics of the patients, together
with toxic habits, lifestyle, past history, digestive complaints are
shown in Table 1, and the results of the urea breath test are shown
in Table 2.
Based on the criteria of Rezende [27] and Ximenes [28], 15
(21.1%) of the patients with CD in our series had digestive
involvement: seven had megacolon, five had esophagopathy, and
three had both megacolon and esophagopathy.
Esophageal Involvement
Barium swallow. Following the Rezende criteria [27],
esophagopathy (stage I) was observed in 8 patients in G1
(11.3%) and in none of those in G2. The related symptoms are
shown in Table 3.
Manometry. Esophageal manometry was performed in 67
patients in G1 and in 14 in G2. Manometry disorders were recorded
in 34 patients in the first group (51.5%) and in six (42.8%) in the
second. Sixteen G1 patients (23.88%) and four G2 patients (28.76%)
had isolated hypotensive LES. Achalasia was observed in two
patients, both from G1. Also in G1, ineffective esophageal motility
was seen in six patients (five with symptoms), diffuse esophageal
spasm in two (one of whom had dysphagia and regurgitation), and
nutcracker esophagus in three (all with symptoms).
Only one G2 patient with isolated hypotensive LES showed
hypertonic upper esophageal sphincter (UES). In G1, there were
six patients with hypertonic UES (one without symptoms, four
with symptoms but without LES involvement, and one with
symptoms and ineffective esophageal motility and hypotonic LES).
The manometry results shown by symptoms for both groups are
summarized in Table 4.
Colonic Involvement: Barium Enema
Megacolon was found in 10 G1 patients (13.9%), three of whom
had stage I esophagopathy, and in none of the G2 patients.
Additionally, dolichocolon (colonic elongation that exceeds the
pelvis) was observed in 44 patients in G1 (62%) and in 14 patients
(77.8%) in G2. A summary of colonopathy-related signs and
symptoms is shown in Table 5.
Regarding Rome III criteria, constipation was found in 48 G1
patients, and among them 12 presented one deposition every
48 hours, 11 every 48–72 hours and 17 every 72 or more hours.
The eight that with constipation that did not presented
constipation presented other constipation defining symptoms.
Discussion
While cardiac involvement has been well described in CD,
gastrointestinal manifestations have received considerably less
attention. Digestive involvement in chronic CD has only been
characterized in certain regions of Brazil, with reports dating back
to the 1950s [12,31–33]. Additionally, the techniques used to
diagnose megaesophagus [27] and megacolon [28] have not been
updated since they were first introduced some 60 years ago. We
have presented the results of digestive damage in a series of Latin
American patients with and without T. cruzi infection seen at an
international health center in Barcelona, Spain. The patients were
mainly from Bolivia, and there are few reports describing the
characteristics of CD in this population [34] Furthermore, few
studies have been performed in Bolivia.
Approximately one in five patients with CD in our series had
digestive problems, a rate that is similar to figures reported in other
series [3,34]. Their symptoms were similar to those observed in
patients without T. cruzi infection from the same geographical
area. Due to the non-specificity of gastrointestinal manifestations
in chronic CD, suspicion of T. cruzi infection is key to making a
diagnosis and serology is mandatory for a definitive diagnosis and
treatment. Regarding specific treatment, it was offered to all
patients that fulfill criteria (64 among 71), and all patients accepted
and completed it.
Eight patients among G1 showed stage I esophagopathy in the
barium swallow, six women and two men. The prevalence of
megaesophagus by gender has resulted in many studies with
controversial results. In a recent study [35] a comparative analyses
between men and women showed that women presented higher
prevalence of stage I involvement. In our series, there is a clear
predominance of young women: even if our results are similar to
those already published, we cannot conclude that it was a
statistically significant difference due to the gender bias of our
cohort. On the other hand, the mean age of Salibaet al. cohort was
54.4 years, and a significant increase in age was observed in
advanced megaesophagus groups. In our series, the mean age was
lower, so that could explain the less esophagopathy progression
showed by patients.
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Dysphagia is a major symptom of esophageal involvement in
CD. In our series, it was detected in seven of the eight patients
diagnosed with stage I esophagopathy, but it was also seen in 15
other patients in G1 who had normal barium swallow and
manometry findings.
Hypertonic LES, a criterion of Chagasic esophagopathy,
[32,33,35,36] was found in three patients in G1, all of whom had
dysphagia. No cases were seen in G2. Hypotonic LES was observed
in 16 (23%) of the 67 patients who underwent manometry in G1
and in four (28.6%) of the 14 patients in G2, indicating that
hypotonic LES is probably related to gastroesophageal reflux
disease and not to CD. Atypical chest pain was reported by 41 G1
patients (57.7%) and eight G2 patients (44.4%). Of the patients with
atypical chest pain, four had hypotensive LES on manometry and in
G1, the patients had abnormal barium swallow and manometric
findings. Atypical chest pain is a non-specific symptom that can be
related to heart damage or other conditions, but it has occasionally
been linked to impaired esophageal microcirculation and has also
Table 1. Baseline characteristics of patients, including past gastrointestinal history.
Group 1 (Chagas +) (N = 71) n (%) Group 2 (Chagas 2) (N = 18) n (%)
Geographical origin
Bolivia 66 (92.9%) 14 (77.8%)
Argentina 3 (4.2%) 2 (11.1%)
Paraguay 2 (2.8%) 0
Colombia 0 2 (11.1%)
Sex
Male 12 (16.9%) 2 (11.1%)
Female 59 (83.1%) 16 (88.9%)
Age (mean, SD) 36 (9) 32 (5)
Lifestyle and toxics habits
Tobacco 2 (2.8%) -
Alcohol intake1 15 (21.1%) 5 (27.8%)
Sedentary lifestyle 43 (60.6%) 12 (66.7%)
Past gastrointestinal history
Dyspepsia2 or peptic ulcer 6 (8.5%) 5 (27.8%)
Esophageal surgery3 1 (1.4%) -
Colon surgery4 5 (7%) 1 (5.6%)
Frequently used drugs
Proton pump inhibitors 8 (11.3%) 1 (5.6%)
Laxatives 1 (1.4%) -
Weight changes 26/41 (63.4%) 2/6 (33%)
1Alcohol intake was reported as occasional in all cases.
2Presence of symptoms considered as originating in the gastroduodenal region, in the absence of any organic, systemic, or metabolic disease that is likely to explain the
symptoms (Roma III criteria).
3One patient presented in her past history pyloric stenosis surgery, showing normal esophagogram and barium enema.
4Five patients presented partial colectomy previously of being admitted in the international health centre. After the surgery, one of them presented megasigma, and
another one dolichomegacolon. The other three presented dolichocolon. All of them did not showed alterations in esophagogram.
doi:10.1371/journal.pntd.0003105.t001
Table 2. Symptoms related to H. pylori infection and analysis of symptoms shared with T. cruzi esophagopathy.
Group 1 (Chagas +) n (%) Group 2 (Chagas 2) n (%)
UBT + UBT 2 Abnormal BS findings1 UBT + UBT 2
Total cases with UBT + or 2 54 8 - 12 3
Dysphagia 17/54 (31.5%) 5/8 (62.5%) 7/8 1/12 (8.3%) 1/3 (33.3%)
Heartburn 18/54 (33.3%) 1/8 (12.5%) 2/8 5/12 (41.7%) 1/3 (33.3%)
Abdominal bloating 27/54 (50%) 2/8 (25%) 4/8 8/12 (66.7%) 3/3 (100%)
Increased thirst 15/54 (27.8%) - 3/8 6/12 (50%) 1/3 (33.3%)
Chest pain 37/54 (68.5%) 5/8 (62.5%) 6/8 5/12 (41.7%) 2/3 (66.7%)
Abbreviations: UBT: urea breath test; BS: barium swallow/esophagogram.
1No abnormal findings in G2.
doi:10.1371/journal.pntd.0003105.t002
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been described as a means of expressing pain due to swallowing in
patients with CD [3]
Achalasia diagnosed by manometry was observed in two G1
patients, both of whom had dysphagia and regurgitation and stage
I esophagopathy in the barium swallow. The three patients with
nutcracker oesophagus in G1 were all symptomatic but had
normal barium swallow findings. On the other hand, studies in
Central Brazil shows that around 10% of achalasia was idiopathic,
and even if patients came for CD endemic regions, in some
countries of Europe the incidence of new cases of achalasia ranged
between 0.018/100.000/year [37] and 1.59 cases/100.000/year
[38,39].
It is important to highlight the correlation between manometric
and barium swallow and clinical findings. The eight patients with
stage I esophagopathy were symptomatic and six had abnormal
manometric findings. Furthermore, 26 of the 33 patients with
normal manometric findings had a normal esophagram. In G1, 10
of the 26 patients with a normal esophagogram had clearly
detectable alterations in manometry: atypical LES relaxation in
one patient with dysphagia, diffuse esophageal spasm in one
patient with regurgitation, nutcracker oesophagus in three patients
(one with dysphagia, one with chest pain, and one with
regurgitation), and ineffective esophageal motility in five patients
(two with dysphagia, two with chest pain, and one with no
symptoms). While manometry has been proposed as a new
technique with diagnostic value in early esophageal damage due to
CD, it is a time-consuming procedure that, furthermore, is
unavailable in most health care centers. Our findings indicate,
however, that it could be useful for detecting incipient esophageal
alterations in asymptomatic patients with T. cruzi infection and
normal barium swallow findings.
Constipation was a common symptom in the two groups, and
was observed in eight of the 10 patients with megacolon.
Dolichocolon, a sedentary lifestyle, and changes in dietary habits
could be at the root of this symptom [34]. Even though
constipation is non-specific, it should not be overlooked in T.
cruzi infection because of its potential clinical implications. In all
the cases in our series, constipation was adequately controlled with
symptomatic treatment, including dietary changes and, in some
cases, laxatives. None of the patients with megacolon required
surgical treatment.
Dolichocolon has not traditionally been considered a sign of CD,
and the results of our study confirm that it probably is not.
Dolichocolon can also be caused by embryological elongation of the
Table 3. Signs and symptoms of esophagopathy and association with esophagogram findings.
Group 1 (T. cruzi-positive) (N = 71)
Patients with clinical symptoms n (%) Esophagopathy (Stage I) (n)
Symptoms1
Dysphagia S 6/71 (8.4) 1
Dysphagia L 11/71(15.5) 3
Dysphagia L and S 8/71 (11.3) 3
Odynophagia 4/71 (5.6) 2
Regurgitation 16/71 (22.5) 3
Chest pain 41/71 (57.7) 6
Abbreviations: LES: lower esophageal sphincter; L: in relation to liquids; S: in relation to solids.
1More than one symptom in some patients.
doi:10.1371/journal.pntd.0003105.t003
Table 4. Manometric patterns and association with symptoms.
Group 1 (T. cruzi-positive) (N = 67) n (%)
Group 2 (T. cruzi-
negative) (N = 14)
n (%)
Manometric Patterns All Asymptomatic Symptomatic
Dysphagia Chest pain Regurgitation
Normal 33(48.5) 11/33 (33) 23/33 (70) 4/33(12) 8 (57.1)
Achalasia 2 (2.9) 0 2/2 (100) 1/2 (50) 2/2 (100) 0
Atypical disorders of LES
relaxation
1(1.5) 0 1/1 (100) 0 0/1 0
Diffuse esophageal spasm 2 (2.9) 0 1/2(50) 0 1/2(50) 0
Nutcracker esophagus 3 (4.4) 0 1/3(33) 2/3 (66) 1/3(33) 0
Ineffective esophageal motility 6 (8.8) 0 3/6 (50) 5/6 (8) 0/6 0
Isolated hypotensive LES 16 (23.5) 3 4/16 (25) 11/16 (69) 1/16 (6) 4 (28.6)
Non-specific esophageal
motility abnormalities
4 (5.6) 0 2/4 (50) 3/4 (75) 2/4 (50) 2 (14.3)
Abbreviation: LES: lower esophageal sphincter.
doi:10.1371/journal.pntd.0003105.t004
Digestive Involvement in Chronic Chagas Disease in Barcelona, Spain
PLOS Neglected Tropical Diseases | www.plosntds.org 5 August 2014 | Volume 8 | Issue 8 | e3105
sigmoid, and in Bolivian patients, it could be related to other factors
such as altitude or long-term consumption of coca leaves [17].
The prevalence of H. pylori infection was high in our series,
consistent with previous reports [15]. Some authors have
hypothesized on a potential relationship between T. cruzi and
H. pylori infections [14], probably in relation to common
environmental risk factors. However, it has been suggested that
hypochlorhydria and/or other gastric dysfunctions caused by T.
cruzi infection could facilitate H. pylori transmission [14].
Classic H. pylori infection symptoms (abdominal bloating,
heartburn, and increased thirst) were common in the two groups,
and are probable confounding factors in the evaluation of patients
with CD. In any case, co-infections should be diagnosed and
treated in order to ameliorate the symptoms.
One limitation of our study is that it was designed and started
before high-resolution manometry was available at our center. It is
likely that esophageal pressure topography analysis would have
detected more esophageal motility disorders than conventional
manometry. However, to guarantee uniformity and taking into
account that high-resolution manometry is not yet widely available,
all studies were performed using conventional manometry.
Conclusions
The prevalence of digestive chronic CD in our series (21.1%)
was at the higher end of the estimated prevalence range.
Dysphagia is a non-pathognomonic symptom of CD, but a good
marker of esophageal involvement, even in early stages of the
disease. Manometry could be a useful diagnostic test in selected
cases, mainly in patients with T. cruzi infection and dysphagia in
whom barium swallow does not evidence alterations. H. pylori co-
infection was common in this series of mostly Bolivian patients,
and the management of this condition may contribute to relieving
digestive symptoms in patients with chronic CD.
Constipation is a common but non-specific symptom that can
cause significant discomfort but is easily managed. Testing for CD
is mandatory in a patient from Latin America with constipation or
dysphagia, and if diagnosis is confirmed, megacolon and
esophageal involvement should be investigated.
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25. Riera C, Vergés M, López-Chejade P, Piron M, Gascon J, et al. (2009)
Desarrollo y evaluación de una técnica ELISA con antı́geno crudo de
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